GSDMA and gastric cancer: Recently, the studies have demonstrated gasdermin (GSDM)-mediated pyroptosis have a critical role in the mechanism of pathogenesis and chemotherapy underlying GC, including proliferation, immune responses, even in chemotherapy resistance[10–15], highlighting that targeting gasdermin family expression is an improvement of therapeutic approaches for gastric malignant disorders.